Nearly Every Democrat in Washington is Joining Forces to Fight Abortion Ruling
The move was made in order to help the Biden administration’s appeal against a Texas judge’s ruling, which suspended FDA approval of a key abortion drug.

Evelyn Hockstein via Reuters
Nearly every Democrat in Washington has joined forces by adding their names to an amicus brief filed in support of the Biden administration’s appeal of a Texas judge’s decision to suspend the Food and Drug Administration’s approval of a key abortion drug. Among the top names are Senate Majority Leader Senator Chuck Schumer (D-NY), Majority Whip and Senate Judiciary Committee Chair Dick Durbin, who say the decision to restrict access to Mifespristone was a “reckless decision by a rogue, Trump-appointed federal judge.” A total of 50 Senators and 190 House Representatives signed the brief, asking the court to stay the district court’s order. “Its perilous consequences reach far beyond mifepristone. Providers and patients rely on the availability of thousands of FDA-approved drugs to treat or manage a range of medical conditions, including asthma, HIV, infertility, heart disease, diabetes, and more,” the lawmakers state.
Today, @SenateDems are filing a brief in the MAGA lawsuit to take away Mifepristone.
— Chuck Schumer (@SenSchumer) April 11, 2023
We’re making clear that Congress gave FDA authority to evaluate and ensure the safety and efficacy of drugs.
This ruling goes against that intent and must be overturned.https://t.co/peIe6oxsRu
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.